Table 1.

Prescribed treatment based on patients/tumor characteristics.

Treatment modulation	Patient/tumor characteristics
Higher dose (70.2 Gy) to the tumor bed	(i) Positive resection margin (ii) Perineural infiltration (iii) Postoperative PSA > 0.2 ng/mL
ENI	(i) pN1 (ii) Lymph node risk > 15%∗ and <10 resected lymph nodes (iii) Gleason score > 7
Short-term (6 months) AHT	(i) pT > 2 (ii) Gleason score = 7
Long-term (24 months) AHT	(i) pN1 (ii) Preoperative PSA > 20 ng/mL (iii) Gleason score > 7

*Based on Roach 3rd [22]. ENI: elective nodal irradiation; AHT: adjuvant hormonal therapy.